Top Executives Share Outlook On Healthcare In The Pulse Publication, To Be Released At The 2009 Wharton Health Care Business Conference, Feb19-20

Share Article

The Wharton Health Care Journal, The Pulse, is an MBA-student organized publication distributed at the Wharton Health Care Business Conference. The latest issue focuses on the future of health care IT, changes in pharmaceutical R&D and the impact of emerging markets on the global healthcare landscape. It includes in-depth interviews with top executives from GE Healthcare Clinical Systems, Google, GlaxoSmithKline, Microsoft, Merck, Oliver Wyman, SV Life Sciences and Beth Israel Deaconess Medical Center.

Philadelphia, PA - The 2009 edition of The Pulse will be released at the 14th annual Wharton Health Care Business Conference, held on February 19-20 at the Park Hyatt At The Bellevue in Philadelphia, PA.

This year's issue features a number of exciting articles, including:

  • The Future of Health Care IT - Personal health records (PHRs) and Electronic Medical Records (EMRs) are center stage in President Obama's health care financing strategy. Interviews with Google, Microsoft and noted healthcare futurist Jeff Goldsmith focus on the impacts of digitizing the patient record
  • 2030 Health Care - Our interviewees outline their views on the biggest changes for the health care system in the next 20 years        
  • Reaching the Target - A discussion of the marketing strategy behind Merck's highly successful launch of the Gardasil vaccine, including novel patient targeting strategies and the impact on the business of demonstrating consumer-driven vaccine demand
  • Rethinking Emerging Market Business Models - India's health-care system is on the move. We discuss GE Healthcare Clinical Systems' strategy to expand access and find profit in this growing market, and also speak with Jubliant Biosys, a leading pharmaceutical development company, about the advantages of researching novel compounds overseas

In addition to these selections, The Pulse has interviews on new directions in medical device development with the former COO of Boston Scientific (now a Venture Partner at SV Life Sciences) and a discussion with University of Pennsylvania Office of Technology Transfer on new models for university-industry partnership.

About the Wharton Health Care Business Conference
Now in its 14th year, the Conference has grown to become a leading health care forum for industry professionals, policy makers academics, and students. This year's conference features CEOs from WebMD, McKesson, Humana, Given Imaging, and DaVita. The annual two-day event typically draws over 600 attendees from across the nation. Attendees represent a broad range of functions including Business Development, Marketing, Corporate Strategy, Finance, and Clinical. To register and learn more about the conference, visit http://www.whcbc.org.

###

Share article on social media or email:

View article via:

Pdf Print